Nuvo Pharms Inc patents expiration
1. Pennsaid patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8217078 | NUVO PHARMS INC | Treatment of pain with topical diclofenac |
Jul, 2029
(5 years from now) | |
| US8618164 | NUVO PHARMS INC | Treatment of pain with topical diclofenac compounds |
Jul, 2029
(5 years from now) | |
| US8741956 | NUVO PHARMS INC | Treatment of pain with topical diclofenac |
Jul, 2029
(5 years from now) | |
| US8546450 | NUVO PHARMS INC | Treatment of pain with topical diclofenac compounds |
Aug, 2030
(6 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| New Dosage Form(NDF) | Nov 04, 2012 |
Drugs and Companies using DICLOFENAC SODIUM ingredient
Market Authorisation Date: 04 November, 2009
Treatment: Use of topical diclofenac on the knee and a second topical medication on the same knee; Use of topical diclofenac on the knee and a second topical prescription medication on the same knee; Combination...
Dosage: SOLUTION;TOPICAL
How can I launch a generic of PENNSAID before it's drug patent expiration?
More Information on Dosage
PENNSAID family patents
